XOMA

XOMA Royalty Corporation

• TipRanks·2d ago

  Xoma downgraded to Hold from Buy at Benchmark

• TipRanks·2d ago

  XOMA Royalty Advances Merger Plans and Governance Changes

• PUBT·2d ago

  XOMA Royalty shareholders approve 2026 employee stock purchase plan with 500,000 shares

• TipRanks·6d ago

  XOMA Royalty amends merger agreement with Ligand Pharmaceuticals

• PUBT·6d ago

  XOMA Royalty amends Ligand merger deal to add HoldCo as party

• PUBT·05/12 20:16

  XOMA Q1 net income falls to $4.5 million; total income and revenues slip to $12.32 million

• Benzinga·04/30 16:15

  This Appian Analyst Is No Longer Bullish; Here Are Top 2 Downgrades For Thursday

• Dow Jones·04/30 10:50

  XOMA Royalty Price Target Announced at $39.00/Share by HC Wainwright & Co.

• Dow Jones·04/30 10:50

  XOMA Royalty Cut to Neutral From Buy by HC Wainwright & Co.

• Benzinga·04/30 10:40

  HC Wainwright & Co. Downgrades XOMA Royalty to Neutral, Announces $39 Price Target

• TipRanks·04/30 10:13

  Xoma downgraded to Neutral from Buy at H.C. Wainwright

• NASDAQ·04/28 09:53

  XOMA Royalty (XOMA) Moves 10.7% Higher: Will This Strength Last?

• TipRanks·04/27 18:10

  Ligand price target raised to $255 from $230 at Stifel

• Reuters·04/27 18:05

  Deals of the day-Mergers and acquisitions

• TipRanks·04/27 18:00

  Ligand price target raised to $260 from $250 at BofA